在案例和病例控制研究中评估疾病病因异质性的效率
Aya Kuchiba1,2, Ran Gao3, Molin Wang4
1Teikyo University Graduate School of Public Health, Tokyo, Japan.
The international journal of biostatistics
|June 3, 2025
概括
与案例研究相比,病例控制研究可以更有效地估计病因异质性参数,特别是在分子流行病学研究中. 这一发现有助于理解不同的疾病亚型及其危险因素.
科学领域:
- 分子流行病学分子流行病学
- 生物统计学 生物统计学
背景情况:
- 疾病可以根据分子或病理特征分为亚型.
- 流行病学研究越来越多地调查疾病亚型的不同病因,称为病因异质性.
- 病例控制和病例研究是评估病因异质性的常见设计.
研究的目的:
- 为了比较病例控制和病例研究设计之间估计病因异质性参数的效率.
- 为这两个研究设计的效率提供理论和数值检查.
- 为了说明这些设计在现实世界流行病学环境中的应用.
主要方法:
- 理论检查参数估计效率的理论检查.
- 数字模拟用于比较研究设计.
- 在乳腺癌研究中应用方法,调查雌激醇和瘤受体状态.
主要成果:
- 案例控制研究始终为异质性参数提供更有效的估计,而不是案例研究,当病例数量相同时.
- 案例控制研究与案例研究相比,提供至少同等的效率.
- 该研究使用乳腺癌数据证明了这两种设计的实际应用.
结论:
- 病例控制研究通常更有效地估计分子流行病学中的病因异质性参数.
- 这些发现支持使用病例控制设计来调查不同的疾病亚型及其病因.
- 了解研究设计效率对于在异质疾病中准确评估风险因素至关重要.
更多相关视频
相关概念视频
Test for Homogeneity
2.4K
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...
2.4K
Introduction to Epidemiology
1.7K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.7K
Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Comparing the Survival Analysis of Two or More Groups
565
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
565
Hazard Ratio
565
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
565


